高级检索
黄志刚, 李学民, 范增林, 王世合, 杨新生, 李春章, 张云杰, 王伟鹏. 食管癌切除术后患者预后的Cox回归分析[J]. 中国公共卫生, 2005, 21(7): 784-785. DOI: 10.11847/zgggws2005-21-07-07
引用本文: 黄志刚, 李学民, 范增林, 王世合, 杨新生, 李春章, 张云杰, 王伟鹏. 食管癌切除术后患者预后的Cox回归分析[J]. 中国公共卫生, 2005, 21(7): 784-785. DOI: 10.11847/zgggws2005-21-07-07
HUANG Zhigang, LI Xuemin, FAN Zenglin, . Cox regression analysis on prognostic factors of patients after curative esophagectomy[J]. Chinese Journal of Public Health, 2005, 21(7): 784-785. DOI: 10.11847/zgggws2005-21-07-07
Citation: HUANG Zhigang, LI Xuemin, FAN Zenglin, . Cox regression analysis on prognostic factors of patients after curative esophagectomy[J]. Chinese Journal of Public Health, 2005, 21(7): 784-785. DOI: 10.11847/zgggws2005-21-07-07

食管癌切除术后患者预后的Cox回归分析

Cox regression analysis on prognostic factors of patients after curative esophagectomy

  • 摘要:
      目的   探讨影响食管癌切除术后患者的预后因素。
      方法   对1992~2000年间接受手术治疗的971例食管癌术后患者预后进行研究。选择14个可能对食管癌切除术后预后产生影响的研究因素, 通过Cox比例风险模型对术后患者预后进行多因素分析, 并估计预后指数, 以及用寿命表法计算累计生存率。
      结果   全组3年生存率78.29%, 5年生存率68.81%, 中位生存期为97.49月。Cox多因素分析表明, 影响预后的独立因素是临床分期、肿瘤部位、侵及深度、分化程度及淋巴结转移个数。
      结论   全组患者3年、5年生存率较高, 食管癌肿瘤临床分期是食管癌切除术后影响预后的重要因素。早期诊断病人, 在临床分期的较早期实施手术, 对患者预后及提高术后生存率具有非常重要意义。

     

    Abstract:
      Objective   To identify prognostic factors in patients with esophageal cancer after curative resection.
      Methods   971 patients operated on for neoplasia of the esophagus, who underwent a curative resection were included in this study.14 variables were studied by univariate analysis.The variables linked with survival were include in a Cox model and then prognostic index(PI)was calculated.Cumulative surviva of the entire population was computed by Life table analysis.
      Results   Cumulative survival at 3 and 5 years was 78.29%, 68.81%, respectively and median survival was 97149 months.In univariate analysis, 10 out of 14 factors were statistically linked with survival.In multivariate analysis(Cox model), 5 independent factors were linked with survival which included:clinical stage, location of tumor, differentiation of tumor, depth of invasion and number of node metastases.
      Conclusion   Cumulative survival at 3, 5 years was relatively high.According to the Wald value, clinical stage was the major prognostic factor affecting the survival of patients with esophageal carcinoma.

     

/

返回文章
返回